Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 YearsAdam Ioannou, Marianna Fontana, Helen J. Lachmann et al.|Circulation|2022Cited by 226
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Francesco Cappelli et al.|Journal of the American College of Cardiology|2024Cited by 137
Conventional heart failure therapy in cardiac ATTR amyloidosisAdam Ioannou, Marianna Fontana, Paolo Massa et al.|European Heart Journal|2023Cited by 136
Prevalence, Characteristics and Outcomes of Older Patients with Hereditary Versus Wild-Type Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Julian D. Gillmore, Yousuf Razvi et al.|European Journal of Heart Failure|2023Cited by 97
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosisMuhammad U. Rauf, Julian D. Gillmore, Philip N. Hawkins et al.|European Heart Journal|2023Cited by 95